Don’t miss outtag icon
Are you tracking AI visibility, or guessing? Get clarity with Similarweb’s AEO ToolkitTry it nowbanner icon

CRUSE Control Urticaria im Vergleich zu EADV Nutzung und Statistiken

CRUSE® is an APP developed by renowned dermatologists and allergoligists to help patients with Chronic Urticaria manage their condition. Take control of your Chronic Urticaria by recording your symptoms and impact on your quality of life in just a few minutes each day. Track how you respond to treatment and how it can be improved by using CRUSE in cooperation with your treating physician. Over 50 million people worldwide have Chronic Urticaria. It is a common condition that causes itchy wheals and/or swellings (angioedema) and can be very debilitating. To ensure optimal treatment, continuous monitoring and documentation of disease activity is essential. From now on, CRUSE® will take care of this for you. Your UCARE Team - With more than 130 member centres in 41 countries, GA²LEN’s Urticaria Centres of Reference and Excellence (UCARE network) is the biggest and most active consortium of urticariologists and urticaria centres. Are you a physician? Find out more on www.cruse-control-com
  • Apple App Store
  • Kostenlos
  • Medizin

Rang speichern

- -

Stay connected with the EADV official app! Get instant access to full scientific programs, abstracts, and ePosters during the annual events. Enjoy on-demand content and easily download your certificates, all in one place!
  • Apple App Store
  • Kostenlos
  • Medizin

Rang speichern

- -

CRUSE Control Urticariavs. EADV Ranking-Vergleich

Vergleichen Sie CRUSE Control Urticaria den Ranking-Trend der letzten 28 Tage mit EADV

Rang

Keine Daten verfügbar

CRUSE Control Urticaria im Vergleich zu EADV Ranking im Ländervergleich

Vergleichen Sie CRUSE Control Urticaria den Ranking-Trend der letzten 28 Tage mit EADV

Alle Kategorien

Keine Daten verfügbar

Medizin

Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an

Los geht's
CRUSE Control Urticaria VS.
EADV

Januar 17, 2026